Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ventilator Associated Pneumonia: Addition of Tobramycin Inhalation Antibiotic Treatment to Standard IV Antibiotic Treatment

NCT02440828 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT02440828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02440828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ventilator Associated Pneumonia: Addition of Tobramycin Inhalation Antibiotic Treatment to Standard IV Antibiotic Treatment
Lead sponsor
Erasmus Medical Center
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2015
Completion date
July 1, 2020
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ventilator associated pneumonia (vap)